Beverley Moore



Beverley practises in all areas of intellectual property litigation with a focus on patent litigation and actions under the Patented Medicines (Notice of Compliance) Regulations.

She also advises clients on IP Regulatory issues such as listing patents on the Patent Register, and reporting patents to the Patented Medicines Prices Review Board, Certificates of Supplementary Protection and the Register of Innovative Drugs as it relates to data protection.

Beverley consults on the implementation and application of the intellectual property provisions of Canada’s trade agreements, including the Comprehensive Economic and Trade Agreement (CETA) between Canada and the European Union and the United States-Mexico-Canada Agreement (USMCA).

In addition, Beverley advises on patent portfolio management, patentability, validity and freedom-to-operate issues, and aids in the prosecution of patent applications in Canada.

Beverley advises on Access to Information requests, in particular those made to Health Canada by pharmaceutical clients.

Beverley has been an advocate before the Federal Courts, the Patented Medicine Prices Review Board and the Supreme Court of Canada. 

Within BLG, Beverley serves on our Thought Leadership Committee, which seeks out innovative ideas to leverage within the firm.


  • Counsel for innovative companies asserting validity and infringement of patents during proceedings brought pursuant to the NOC Regulations.
  • Counsel for innovative companies challenging and judicially reviewing the Minister of Health’s refusal to list patents on the Patent Register.
  • Counsel for innovative companies defending generic companies’ claims for damages pursuant to s. 8 of the NOC Regulations.
  • Counsel for innovative companies in patent infringement and validity proceedings involving claims to compounds, formulations and uses of drugs and the processes to make them.
  • Advising clients on patent portfolio issues relating to data protection, listing patents on the Patent Register and reporting to the Patented Medicines Prices Review Board.
  • Preparing freedom-to-operate, infringement and validity opinions with respect to intellectual property matters.
  • Counsel for clients seeking leave to intervene and intervening in proceedings before the Supreme Court of Canada.
  • Counsel for clients seeking leave to intervene and intervening in proceedings before the Patented Medicines Prices Review Board.

Beyond Our Walls

Professional Involvement

  • Member, BIOTECanada’s Health Advisory Board and Subsequent Entry Biologics Task Force
  • Member, Intellectual Property Institute of Canada (IPIC), IPIC Editorial Board for the Canadian Intellectual Property Review, IPIC Competition Law
  • Vice Co-Chair, Intellectual Property Owners Association (IPO), Pharmaceutical & Biotechnology Issues Committee
  • Member, American Bar Association (ABA), IP Section and the ABA Committees on Patents in the Chemical & Life Sciences and International Patent Treaties & Laws
  • Member, Canadian Bar Association (CBA), Court Practice Committee
  • Member, Advocate’s Society
  • Member, American Intellectual Property Law Association
  • Member, County of Carleton Law Association

Awards & Recognitions

  • Recognized in the 2020 and 2019 edition of The Best Lawyers in Canada® (Intellectual Property Law) and in 2020 (Biotechnology).
  • Selected by peers for inclusion in the 2019 edition of The Best Lawyers in Canada® (Intellectual Property Law).

Bar Admission & Education

  • Ontario, 2003
  • LLB, Queen's University, 2002
  • MSc, Biochemistry, Queen's University, 2000
  • BSc (Hons.), Biochemistry, Queen's University, 1997